XINHUA PHARMA -H- (XIN.SG)
XINHUA PHARMA -H- (XIN.SG) operates in Diversified Metals & Mining.
Market Cap & Net Worth: XINHUA PHARMA -H- (XIN.SG) (XIN)
XINHUA PHARMA -H- (XIN.SG) (STU:XIN) has a market capitalization of $6.99K (€6.81K) as of March 19, 2026. Listed on the STU stock exchange, this Germany-based company holds position #45569 globally and #7538 in its home market, demonstrating a 2.13% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying XINHUA PHARMA -H- (XIN.SG)'s stock price €0.72 by its total outstanding shares 9461 (9.46K).
XINHUA PHARMA -H- (XIN.SG) Market Cap History: 2015 to 2026
XINHUA PHARMA -H- (XIN.SG)'s market capitalization history from 2015 to 2026. Data shows growth from $432.16 to $6.99K (31.08% CAGR).
XINHUA PHARMA -H- (XIN.SG) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how XINHUA PHARMA -H- (XIN.SG)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
XINHUA PHARMA -H- (XIN.SG)'s market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.00x
XINHUA PHARMA -H- (XIN.SG)'s market cap is 0.00 times its annual earnings
0.00x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $473.92 | $4.01 Billion | $122.27 Million | 0.00x | 0.00x |
| 2017 | $692.43 | $4.52 Billion | $209.59 Million | 0.00x | 0.00x |
| 2018 | $311.74 | $5.21 Billion | $250.83 Million | 0.00x | 0.00x |
| 2019 | $466.15 | $5.61 Billion | $299.97 Million | 0.00x | 0.00x |
| 2020 | $543.84 | $6.01 Billion | $324.86 Million | 0.00x | 0.00x |
| 2021 | $1.45K | $6.56 Billion | $348.55 Million | 0.00x | 0.00x |
| 2022 | $3.25K | $7.50 Billion | $411.06 Million | 0.00x | 0.00x |
| 2023 | $3.36K | $8.10 Billion | $496.51 Million | 0.00x | 0.00x |
Competitor Companies of XIN by Market Capitalization
Companies near XINHUA PHARMA -H- (XIN.SG) in the global market cap rankings as of March 19, 2026.
Key companies related to XINHUA PHARMA -H- (XIN.SG) by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
XINHUA PHARMA -H- (XIN.SG) Historical Marketcap From 2015 to 2026
Between 2015 and today, XINHUA PHARMA -H- (XIN.SG)'s market cap moved from $432.16 to $ 6.99K, with a yearly change of 31.08%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €6.99K | +3.60% |
| 2025 | €6.75K | +0.72% |
| 2024 | €6.70K | +99.60% |
| 2023 | €3.36K | +3.29% |
| 2022 | €3.25K | +123.73% |
| 2021 | €1.45K | +167.14% |
| 2020 | €543.84 | +16.67% |
| 2019 | €466.15 | +49.53% |
| 2018 | €311.74 | -54.98% |
| 2017 | €692.43 | +46.11% |
| 2016 | €473.92 | +9.66% |
| 2015 | €432.16 | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of XINHUA PHARMA -H- (XIN.SG) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.99K USD |
| MoneyControl | $6.99K USD |
| MarketWatch | $6.99K USD |
| marketcap.company | $6.99K USD |
| Reuters | $6.99K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.